Publicacions en què col·labora amb Alfredo Carrato Mena (9)

2017

  1. Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

    Scientific Reports, Vol. 7

2011

  1. Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

    Clinical and Translational Oncology, Vol. 13, Núm. 6, pp. 411-418

2010

  1. Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

    European Journal of Cancer Care, Vol. 19, Núm. 5, pp. 648-655

2009

  1. Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer

    Lung Cancer, Vol. 63, Núm. 1, pp. 83-87

2003

  1. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: A Spanish Lung Cancer Group phase III randomized trial

    Journal of Clinical Oncology, Vol. 21, Núm. 17, pp. 3207-3213

2001

  1. Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 19, Núm. 4, pp. 1071-1077

1999

  1. Randomized phase III study of Gemcitabine-cisplatin versus Etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

    Pneumologie, Vol. 53, Núm. 5

  2. Randomized phase III study of gemcitabine-cisplatin versus etoposide- cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 17, Núm. 1, pp. 12-18

1994

  1. ESTUDIO CON REPARTO ALEATORIO DE NAVELBINA FRENTE A NAVELBINA Y CISPLATINO FRENTE A VINDESINA Y CISPLATINO EN EL TRATAMIENTO DEL CARCINOMA PULMONAR NO MICROCELULAR INOPERABLE. RESULTADOS DE UN ESTUDIO MULTICENTRICO EUROPEO INCLUYENDO 612 PACIENTES

    Revista Clinica Espanola, Vol. 194, Núm. 11, pp. 953-959